The Regulation was evaluated in 2016 as part of the Commission's regulatory fitness and performance programme (REFIT) including on the scope of countries and diseases and general criteria for the implementation of Article 3.
Asetus arvioitiin vuonna 2016 osana komission sääntelyn toimivuutta ja tuloksellisuutta koskevaa ohjelmaa (REFIT).